352 related articles for article (PubMed ID: 31326196)
21. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.
Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA
Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952
[TBL] [Abstract][Full Text] [Related]
22. [Clinicopathological features of inflammatory myofibroblastic tumor].
Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
[No Abstract] [Full Text] [Related]
23. Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation.
Siminovich M; Galluzzo L; López J; Lubieniecki F; de Dávila MT
Pediatr Dev Pathol; 2012; 15(3):179-86. PubMed ID: 22280150
[TBL] [Abstract][Full Text] [Related]
24. Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene.
Saiki M; Ohyanagi F; Ariyasu R; Koyama J; Sonoda T; Nishikawa S; Kitazono S; Yanagitani N; Horiike A; Ninomiya H; Ishikawa Y; Nishio M
Jpn J Clin Oncol; 2017 Dec; 47(12):1189-1192. PubMed ID: 28977547
[TBL] [Abstract][Full Text] [Related]
25. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract][Full Text] [Related]
26. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
Lawrence B; Perez-Atayde A; Hibbard MK; Rubin BP; Dal Cin P; Pinkus JL; Pinkus GS; Xiao S; Yi ES; Fletcher CD; Fletcher JA
Am J Pathol; 2000 Aug; 157(2):377-84. PubMed ID: 10934142
[TBL] [Abstract][Full Text] [Related]
27. Intraocular inflammatory myofibroblastic tumor with ALK overexpression.
O'Malley DP; Poulos C; Czader M; Sanger WG; Orazi A
Arch Pathol Lab Med; 2004 Jan; 128(1):e5-7. PubMed ID: 14692830
[TBL] [Abstract][Full Text] [Related]
28. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
[TBL] [Abstract][Full Text] [Related]
29. ALK probe rearrangement in a t(2;11;2)(p23;p15;q31) translocation found in a prenatal myofibroblastic fibrous lesion: toward a molecular definition of an inflammatory myofibroblastic tumor family?
Sirvent N; Hawkins AL; Moeglin D; Coindre JM; Kurzenne JY; Michiels JF; Barcelo G; Turc-Carel C; Griffin CA; Pedeutour F
Genes Chromosomes Cancer; 2001 May; 31(1):85-90. PubMed ID: 11284039
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory Myofibroblastic Tumor Driven by Novel
Rao N; Iwenofu H; Tang B; Woyach J; Liebner DA
J Natl Compr Canc Netw; 2018 Feb; 16(2):115-121. PubMed ID: 29439172
[TBL] [Abstract][Full Text] [Related]
31. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.
Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X
Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study.
Yamamoto H; Yamaguchi H; Aishima S; Oda Y; Kohashi K; Oshiro Y; Tsuneyoshi M
Am J Surg Pathol; 2009 Sep; 33(9):1330-40. PubMed ID: 19718789
[TBL] [Abstract][Full Text] [Related]
33. [Inflammatory myofibroblastic tumor].
Leuschner I
Pathologe; 2010 Mar; 31(2):106-8. PubMed ID: 20063099
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review.
Craig E; Wiltsie LM; Beaupin LK; Baig A; Kozielski R; Rothstein DH; Li V; Twist CJ; Barth M
J Pediatr Surg; 2021 Dec; 56(12):2364-2371. PubMed ID: 33676744
[TBL] [Abstract][Full Text] [Related]
35. Intracranial Inflammatory Myofibroblastic Tumor with Negative Expression of Anaplastic Lymphoma Kinase: A Case Report and Review of the Literature.
Wang X; Chen Y; Wu X; Zhang H
World Neurosurg; 2019 May; 125():117-122. PubMed ID: 30735872
[TBL] [Abstract][Full Text] [Related]
36. Uterine inflammatory myofibroblastic tumor presented as abnormal uterine bleeding: Two cases report and literature review.
Tang F; Dai G; Huang X; Wang D
Medicine (Baltimore); 2022 Dec; 101(50):e32141. PubMed ID: 36550868
[TBL] [Abstract][Full Text] [Related]
37. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor.
Bridge JA; Kanamori M; Ma Z; Pickering D; Hill DA; Lydiatt W; Lui MY; Colleoni GW; Antonescu CR; Ladanyi M; Morris SW
Am J Pathol; 2001 Aug; 159(2):411-5. PubMed ID: 11485898
[TBL] [Abstract][Full Text] [Related]
38. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.
Yamamoto H; Oda Y; Saito T; Sakamoto A; Miyajima K; Tamiya S; Tsuneyoshi M
Histopathology; 2003 May; 42(5):431-9. PubMed ID: 12713619
[TBL] [Abstract][Full Text] [Related]
39. A Comparative Study of Inflammatory Myofibroblastic Tumors and Tumefactive IgG4-related Inflammatory Lesions: the Relevance of IgG4 Plasma Cells.
Chougule A; Bal A; Das A; Agarwal R; Singh N; Rao KL
Appl Immunohistochem Mol Morphol; 2016; 24(10):721-728. PubMed ID: 26469330
[TBL] [Abstract][Full Text] [Related]
40. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]